National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

AEG35156
A second-generation synthetic antisense oligonucleotide with potential antineoplastic activity. AEG35156 selectively blocks the cellular expression of X-linked inhibitor of apoptosis protein (XIAP), a pivotal inhibitor of apoptosis that is overexpressed in many tumors. This agent reduces total levels of XIAP in tumor cells, working synergistically with cytotoxic drugs to overcome tumor cell resistance to apoptosis. XIAP interferes with both the intrinsic and extrinsic program-death signaling pathways, which may render tumor cells resistant to apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:GEM640



Previous:Adriamycin PFS, Adriamycin RDF, Adrucil, ADVEXIN, AEE788
Next:Aeroseb-Dex, Aeroseb-HC, aerosol sargramostim, aerosolized liposomal 9-nitro-20 (S) camptothecin, Affinitac

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov